SCHEMBL3769966

SCHEMBL3769966

Oc1ccc(-c2ccccc2)cc1/N=C/c1ccc(-c2ccccc2C(F)(F)F)o1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPFFR1 Q9GZQ6 3/20 0.54
▸ NPFFR2 Q9Y5X5 3/20 0.54
▸ TNFRSF1A P19438 3/20 0.41
▸ ALDH1A1 P00352 6/20 0.39
▸ HPGD P15428 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ GFER P55789 1/20 0.39
▸ GAA P10253 3/20 0.38
▸ LMNA P02545 2/20 0.38
▸ POLB P06746 2/20 0.38
▸ SLC9A1 P19634 1/20 0.38
▸ KDM4E B2RXH2 4/20 0.38
▸ HTT P42858 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MAPT P10636 3/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ GLA P06280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3678992 1.00 NPFFR1 (0.54) NPFFR1NPFFR2TNFRSF1AALDH1A1HPGD
SCHEMBL3765667 0.86 NPFFR1 (0.55) NPFFR1NPFFR2TNFRSF1AALDH1A1HPGD
SCHEMBL3680711 0.86 NPFFR1 (0.55) NPFFR1NPFFR2TNFRSF1AALDH1A1HPGD
SCHEMBL3770162 0.86 NPFFR1 (0.55) NPFFR1NPFFR2TNFRSF1AALDH1A1HPGD
SCHEMBL3765671 0.86 NPFFR1 (0.55) NPFFR1NPFFR2TNFRSF1AALDH1A1HPGD
SCHEMBL3682013 0.85 NPFFR1 (0.62) NPFFR1NPFFR2TNFRSF1AALDH1A1HPGD
SCHEMBL3764031 0.85 NPFFR1 (0.62) NPFFR1NPFFR2TNFRSF1AALDH1A1HPGD
SCHEMBL3677905 0.84 NPFFR1 (0.53) NPFFR1NPFFR2TNFRSF1AALDH1A1HPGD
SCHEMBL3769958 0.84 NPFFR1 (0.53) NPFFR1NPFFR2TNFRSF1AALDH1A1HPGD
SCHEMBL3685385 0.79 KDM4E (0.49) NPFFR1NPFFR2ALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426540-B2 Tridentate ligand compounds with imino furan units, method for manufacturing said compounds, and their use in the preparation of catalysts for the homopolymerisation and copolymerisation of ethylene and alpha-olefins TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2013-04-23 — — US claimed
US-20100311930-A1 New Tridentate Ligand Compounds with Imino Furan Units, Method for Manufacturing Said Compounds, and their use in the Preparation of Catalysts for the Homopolymerisation and Copolymerisation of Ethylene and Alpha-Olefins TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2010-12-09 — — US claimed
EP-2003125-A1 NEW TRIDENTATE LIGAND COMPOUNDS WITH IMINO FURAN UNITS, METHOD FOR MANUFACTURING SAID COMPOUNDS, AND THEIR USE IN THE PREPARATION OF CATALYSTS FOR THE HOMOPOLYMERISATION AND COPOLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2008-12-17 — — EP claimed
US-8426540-B2 Tridentate ligand compounds with imino furan units, method for manufacturing said compounds, and their use in the preparation of catalysts for the homopolymerisation and copolymerisation of ethylene and alpha-olefins TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2013-04-23 — — US disclosed
US-20100311930-A1 New Tridentate Ligand Compounds with Imino Furan Units, Method for Manufacturing Said Compounds, and their use in the Preparation of Catalysts for the Homopolymerisation and Copolymerisation of Ethylene and Alpha-Olefins TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2010-12-09 — — US disclosed
EP-2003125-A1 NEW TRIDENTATE LIGAND COMPOUNDS WITH IMINO FURAN UNITS, METHOD FOR MANUFACTURING SAID COMPOUNDS, AND THEIR USE IN THE PREPARATION OF CATALYSTS FOR THE HOMOPOLYMERISATION AND COPOLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2008-12-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311930-A1 New Tridentate Ligand Compounds with Imino Furan Units, Method for Manufacturing Said Compounds, and their use in the Preparation of Catalysts for the Homopolymerisation and Copolymerisation of Ethylene and Alpha-Olefins FDFT1, ETFB, ETFA NPFFR1 1999/4885NPFFR2 2601/4885TNFRSF1A 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback